Comparison of The Influence of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function For Patients With ST-Segment Elevation Myocardial Infarction Receiving Emergency Percutaneous Coronary Intervention
Status: Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms TIGERCAVE
- 31 Aug 2018 Biomarkers information updated
- 24 Feb 2015 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.